Status
Conditions
Treatments
About
evaluate the Efficacy of high flow nasal oxygen as a weaning strategy in mechanically ventilated patients with respiratory failure.
Full description
Acute respiratory failure is a main cause of IMV and admission to intensive care unit (ICU){1}.
The day of extubation is a critical time during an intensive care unit (ICU) stay because in case of postextubation failure {2},which reach to 25 - 40% from extubated patient associated with VAP and barotrauma, mortality rate and hospital stay will increase , we use Adjuvant oxygen therapy to prevent these undesirable event like COT ,NIV and High-flow nasal cannula (HFNC) which can be used as an initial weaning strategy from IMVdue to its physiologic benefits [3-4].
HFNC devices supply between 30 and 60 L/min of a controlled mixture of actively warmed (32-37 °C) and humidified (up to 100% relative humidity) oxygen and air through modified nasal prongs. producing {5-6-7}:
Mechanisms:
e) humidification may improve mucus drainage and reduce mucus retention, alleviating the associated atelectasis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
1- All adult patients who were admitted to our ICU requiring endotracheal intubation (ETI), were eligible for the study.
Exclusion criteria
Loading...
Central trial contact
Hamed Fr Qenawy, Bachelor; Doaa Mo Magdy, Lecturer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal